Outcome measures include frailty status using Fried criteria and Frailty Index accumulation of deficit, selected frailty biomarkers (interleukin-6, tumor necrosis factor-alpha, and insulin-like growth factor-1), physical function, cognitive function, nutritional status and biochemical profile
Most patients notice appetite reduction within the first one to two weeks of starting treatment, with effects intensifying as the dose increases over subsequent months
Prevention, switch, and augmentation strategies The cornerstone of preventing AIWG is antipsychotic selection
MLM received lecture or consultancy fees from Amarin, Amgen, AstraZeneca, Eli Lilly, MSD, Novo Nordisk, SlaPharma, and Servier
Quick Answer: Tirzepatide and metformin together provide complementary diabetes control by targeting different metabolic pathwaysmetformin reduces hepatic glucose production while tirzepatide enhances insulin secretion and promotes weight loss
This product is sold strictly for in-vitro laboratory research purposes